Coordinating Healthcare with Artificial Intelligence-supported Technology in Atrial Fibrillation: CHAT-AF

Not Applicable

• Conditions: Atrial Fibrillation; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12621000174886
• Lead Sponsor: Western Sydney Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-18
• Study Completion: 2022-06-03
• Last Update Posted: 27 February 2023

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 103

Inclusion Criteria

Patients will be eligible to participate if they (1) are >18 years old, (2) have a documented diagnosis of AF, (3) have a mobile phone that is able to receive calls, (4) are able to receive SMS or emails and open weblinks embedded in them, and (5) are competent with English, as ascertained by the study researcher.

Exclusion Criteria

Participants will be excluded from the study if they (1) are participating in a concurrent clinical trial focusing on atrial fibrillation (2) have a concomitant illness, physical impairment or mental condition which in the opinion of the study team/primary care physician could interfere with the conduct of the study including outcome assessment (e.g. hearing impairment not corrected by a digital hearing aid), (3) are pregnant, (4) have a medical illness with anticipated life expectancy of < 3 years, and (5) are unable or unwilling to provide written consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified